Diagnostic marker for breast cancer, having thioredoxin-1 as an active ingredient, and diagnostic kit for breast cancer using same

Marqueur de diagnostic du cancer du sein comprenant de la thiérodoxine-1 comme ingrédient actif et trousse de diagnostic du cancer du sein utilisant ledit marqueur

Diagnostischer marker für brustkrebs mit thioredoxin-1 als wirkstoff sowie diagnostisches kit damit für brustkrebs

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (6)

    CHA MEE-KYUNG ET AL: "Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma", JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, BIOMED CENTRAL LTD, LONDON UK, vol. 28, no. 1, 30 June 2009 (2009-06-30), pages 93, XP021060930, ISSN: 1756-9966, DOI: 10.1186/1756-9966-28-93
    LINCOLN DAVID T ET AL: "The thioredoxin-thioredoxin reductase system: Over-expression in human cancer.", ANTICANCER RESEARCH, vol. 23, no. 3B, May 2003 (2003-05-01), pages 2425 - 2434, XP008155196, ISSN: 0250-7005
    MATSUTANI Y ET AL: "Inverse correlation of thioredoxin expression with estrogen receptor- and p53-dependent tumor growth in breast cancer tissues", vol. 7, no. 11, 1 November 2001 (2001-11-01), pages 3430 - 3436, XP008155194, ISSN: 1078-0432, Retrieved from the Internet
    S. J. KIM: "High Thioredoxin Expression Is Associated with Resistance to Docetaxel in Primary Breast Cancer", CLINICAL CANCER RESEARCH, vol. 11, no. 23, 1 December 2005 (2005-12-01), pages 8425 - 8430, XP055036040, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-05-0449
    See also references of WO 2010107158A1
    YEGHIAZARYAN KRISTINA ET AL: "Irradiated breast cancer patients demonstrate subgroupspecific regularities in protein expression patterns of circulating leukocytes", CANCER GENOMICS & PROTEOMICS, INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH, GR, vol. 4, no. 6, 1 November 2007 (2007-11-01), pages 411 - 418, XP008155195, ISSN: 1109-6535

Cited By (0)

    Publication numberPublication dateAssigneeTitle